Screener
Vertex Pharmaceuticals VRTX Other revenues — Product revenues, net
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Vertex Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The source filing: Vertex Pharmaceuticals’s 10-Q, filed May 5, 2026.
- Filed
- May 5, 2026, 4:08 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0000875320-26-000173
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Revenues: | ||
| Product revenues, net | $2,986.9 | $2,760.2 |
| Other revenues | — | 10.0 |
| Total revenues | 2,986.9 | 2,770.2 |
| Costs and expenses: | ||
| Cost of sales | 392.8 | 363.0 |
| Research and development expenses | 961.6 | 979.7 |
| Acquired in-process research and development expenses | 0.5 | 19.8 |
Item 1. Financial Statements (unaudited)
FAQ
- What is Vertex Pharmaceuticals's other revenues — product revenues, net?
- Vertex Pharmaceuticals (VRTX) reported other revenues — product revenues, net of $0 in Q1 2026.
- How has Vertex Pharmaceuticals's other revenues — product revenues, net changed year-over-year?
- Vertex Pharmaceuticals's other revenues — product revenues, net decreased by 100.0% year-over-year, from $10M to $0.
- What is the long-term trend for Vertex Pharmaceuticals's other revenues — product revenues, net?
- Over 4 years (2021 to 2025), Vertex Pharmaceuticals's other revenues — product revenues, net has grown at a 135.4% compound annual growth rate (CAGR), from $1M to $30.7M.
- What does other revenues — product revenues, net mean?
- This metric represents net product sales generated from secondary or emerging business segments outside of the company's primary therapeutic franchises. It captures revenue streams from specialized products, collaborative ventures, or early-stage commercial assets that do not fall under the core cystic fibrosis portfolio. This figure reflects the company's ability to diversify its commercial footprint beyond its established market-leading therapies.
Ask your AI about Vertex Pharmaceuticals's other revenues — product revenues, net.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude